Valsartan/HCTZ 160 mg/12.5 mg tablet, 90-count bottle, Rx only, RemedyRepack, 625 Kolter Drive, Suite 4, Indiana, PA 15701
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot # B0318652-070617; Exp. 07/18
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- RemedyRepack Inc.
- Reason for Recall:
- CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Valsartan/HCTZ 160 mg/12.5 mg tablet, 90-count bottle, Rx only, RemedyRepack, 625 Kolter Drive, Suite 4, Indiana, PA 15701
Product Codes/Lot Numbers:
Lot # B0318652-070617; Exp. 07/18
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-1020-2018
Related Recalls
Class I - Dangerous
CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets.
Class I - Dangerous
CGMP Deviations
Class I - Dangerous
CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.